INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF WOMEN WITH MULTIPLE MISCARRIAGES

被引:45
作者
CHRISTIANSEN, OB
MATHIESEN, O
LAURITSEN, JG
GRUNNET, N
机构
[1] Department of Clinical Immunology, Aalborg Hospital, DK 9100, Aalborg
[2] Department of Obstetrics and Gynaecology, Aalborg Hospital, DK 9100, Aalborg
关键词
ABORTION; IMMUNOGLOBULIN; RECURRENT ABORTION;
D O I
10.1093/oxfordjournals.humrep.a137724
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Eleven women who had previously experienced four to eight unexplained fetal losses (median 6.0 fetal losses/woman) were treated in their next pregnancy with individualized doses of pooled intravenous immunoglobulins. Nine women (82%) delivered healthy infants subsequent to the treatment. Prior to treatment, the pregnant patients had a significantly (P < 0.05) increased median level of complement C3 neodeterminants in the blood compared with a group of 33 normal first trimester pregnant women. This may be a sign of increased turnover of complement in these women.
引用
收藏
页码:718 / 722
页数:5
相关论文
共 26 条
[1]  
Ammann A.J., Ashman R.F., Buckley R.H., Nardie W.R., Krantmann H.J., Nelson J., Ochs M., Stiehm E.R., Tiller R., Wara D.W., Wedgwood R., Use of intravenous gammaglobulin in antibody immunodeficiency: Results of a multicenter controlled trial, Clin. Immunol. Immunopathol, 22, (1982)
[2]  
Boackle R.J., Pruitt K.M., A convenient method for the study of anticomplementary substances in biological fluids, Protides in the Biological Fluids, pp. 613-617, (1974)
[3]  
Carreras L., Perez G.N., Vega H.R., Casavilla F., Lupus anticoagulant and recurrent fetal loss: Successful treatment with gammaglobulin, Lancet, 2, pp. 393-394, (1988)
[4]  
Cauchi M.N., Lim D., Young D.E., Kloss M., Pepperell R.J., Treatment of recurrent aborters by immunization with paternal cells-Controlled trial, Am, J. Reprod. Immunol, 25, pp. 16-17, (1991)
[5]  
Christiansen O.B., Mathiesen O., Riisom K., Lauritsen J.G., Grunnet N., Jersild C., HLA or HLA-linked genes reduce birthweight in families affected by idiopathic recurrent abortion, Tissue Antigens, 36, pp. 156-163, (1990)
[6]  
Espersen G.T., Langeland B., Grunnet N., Comparative study of assays detecting complement acdvation. Complement-split product C3d (rocket-electrophoresis) and C3d neodeterminants (ELISA, Scand, J. Clin. Invest, 50, (1990)
[7]  
Hilfenhaus J., Weidmann E., Pasteurization as an efficient method to inactivate blood bo me viruses in Factor VIII concentrates, Drug. Res, 36, pp. 621-625, (1986)
[8]  
Ho H., Gill T.J., Hsieh H., Jiang J., Lee T., Hsieh C., Immunotherapy for recurrent spontaneous abortion in a Chinese population, Am, J. Reprod. Immunol, 25, pp. 10-15, (1991)
[9]  
Hsi B., Hunt J.S., Atkinson J.P., Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells, J. Reprod. Immunol, 19, (1991)
[10]  
Imbach P., Barandun S., D'apuzzo V., Baumgartner C., Hirt A., Morell A., Rossi E., Scholini M., Vest M., Wagner H.P., High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood, Lancet, 1, pp. 1228-1231, (1981)